Posts Tagged ‘
Novartis ’
Nov 30th, 2012 |
By Jeffry John Aufderheide
In 2011, the US Federal government awarded 6 pharmaceutical corporations over $5.7 Billion to manufacture vaccines children’s vaccines alone.
Posted in Jeffry John Aufderheide, Recent Articles, Top Stories |
20 comments
Tags: 200-2011-38199, 200-2011-38200, 200-2011-38201, 200-2011-38202, 200-2011-38203, 200-2011-38204, GlaxoSmithKline (GSK), MassBiologics, Merck, Novartis, pfizer, Sanofi Pasteur, U.S. Centers for Disease Control and Prevention (CDC), vaccine schedule, Vaccines for Children (VFC)
Apr 13th, 2010 |
By VT
. . . . Rob Evans and Sarah Boseley guardian.co.uk 04/11/2010 The pharmaceutical firms Novartis and Roche have threatened to pull out of Britain and relocate thousands of jobs abroad, in an ongoing row over pricing for the NHS and rules surrounding safety trials. The Swiss drug companies made their threats known in personal meetings…
[Continue reading]
Posted in Top Stories |
No Comments »
Tags: Novartis, Roche, Vaccine
Jan 28th, 2010 |
By VT
Source: AFP BASEL, Switzerland — The head of Swiss pharmaceutical giant Novartis on Tuesday warned that governments now trying to cancel swine flu vaccine contracts might not be dealt with so swiftly in the next pandemic. Chairman and chief executive Daniel Vasella said those that had been reliable partners would be favoured. “The same governments…
[Continue reading]
Posted in Top Stories |
No Comments »
Tags: Daniel Vasella, h1n1 scam, Novartis, Vaccine
Oct 27th, 2009 |
By VT
Swiss pharmaceutical group Novartis on Monday denied that it faced hurdles in gaining regulatory approval in Switzerland for one of its swine flu vaccines because of possible bacterial contamination.
Posted in Top Stories |
No Comments »
Tags: Celtura, chicken eggs, contaminiation, dog kidneys, flu shot, H1N1 shot, Novartis, Swine Flu Vaccine, Vaccine
Oct 5th, 2009 |
By VT
Withholding this information from volunteers violates informed consent standards upheld by the Nuremberg Code.
Posted in Top Stories |
2 comments
Tags: adjuvant, AS03, Gary Matsumoto, GlaxoSmithKline, H1N1 Vaccine, HHS, lupus, MF59, MS, multiple sclerosis, Myelin, NHS, Novartis, Rheumatoid arthritis, squalene, Swine Flu Vaccine, Vaccine